Parallel factor analysis and trilinear partial least squares applied to the UPLC-PDA data array for the quantification of brimonidine tartrate and timolol maleate in an eye drop formulation

References

• Greenfield, D. S.; Liebmann, J. M.; Ritch, R. Brimonidine: A New Alpha2-adrenoreceptor Agonist for Glaucoma Treatment. J. Glaucoma. 1997, 6, 250–258.
   PubMed Web of Science ®Google Scholar
• Schuman, J. S.; Horwitz, B.; Choplin, N. T.; David, R.; Albracht, D.; Chen, K. A 1-Year Study of Brimonidine Twice Daily in Glaucoma and Ocular Hypertension. A Controlled, Randomized, Multicenter Clinical Trial. Arch. Ophthalmol. 1997, 115, 847–852.
   PubMed Web of Science ®Google Scholar
• Katz, L. J. Brimonidine Tartrate 0.2% Twice Daily vs Timolol 0.5% Twice Daily: 1-Year Results in Glaucoma Patients. Am. J. Ophthalmol. 1999, 127, 20–26.
   PubMed Web of Science ®Google Scholar
• Le Blanc, R. P. Twelve-month Results of an Ongoing Randomized Trial Comparing Brimonidine Tartrate 0.2% and Timolol 0.5% Given Twice Daily in Patients with Glaucoma or Ocular Hypertension. Ophthalmology 1998, 105, 1960–1967.
   PubMed Web of Science ®Google Scholar
• Schuman, J. S. Clinical Experience with Brimonidine 0.2% and Timolol 0.5% in Glaucoma and Ocular Hypertension. Surv. Ophthalmol. 1996, 41, 27–37.
   PubMed Web of Science ®Google Scholar
• Serle, J. B. A Comparison of the Safety and Efficacy of Twice Daily Brimonidine 0.2% Versus Betaxolol 0.25% in Subjects with Elevated Intraocular Pressure. Surv. Ophthalmol. 1996, 41, 39–47.
   PubMed Web of Science ®Google Scholar
• Burke, J.; Manlapaz, C.; Kharlamb, A.; Runde, E.; Padillo, E.; Spada, C.; Nieves, A.; Munk, S.; MacDonald, T.; Garst, M. Therapeutic Use of a2-Adrenoceptor Agonists in Glaucoma. In Alpha2-adrenergic Receptors: Structure, Function and Therapeutic Implications; Lanier, S., Limbird, L., Eds.; Harwood Academic: Reading, UK, 1996, 179–187.
   Google Scholar
• Uusitalo, H.; Kahonen, M.; Ropo, A.; Turjanmaa, V. The Evaluation of Efficacy and Systemic Side Effects of Topical Antiglaucoma Drugs: The Benefits of Improved Drug Formulation. J. Glaucoma 1999, 8, 264–265.
   Google Scholar
• Zimmerman, T. J. Timolol Maleate—A New Glaucoma Medication. Invest. Ophthalmol. Vis. Sci. 1977, 16, 687–688.
   PubMed Web of Science ®Google Scholar
• Mohammedi, H.; Shyale, S.; Shanta Kumar, S. M. Physico-chemical Characterization, UV Spectrophotometric Method Development and Validation Studies of Timolol Maleate. Int. J. Pharm. Sci. Rev. Res. 2011, 6, 163–166.
   Google Scholar
• El-Didamony, A. M.; Erfan, E. A. H. Spectrophotometric Determination of β-Blocker Drugs by Oxidation with Bromate-Bromide Mixture and its Analytical Application to Pharmaceutical Preparations. Spectroscopy 2011, 25, 303–315.
   Web of Science ®Google Scholar
• Al-Ghamdi, A. F. Determination of Timolol Drug in Pharmaceuticals and Biological Fluids. Am. J. Anal. Chem. 2011, 2, 174–181.
   Google Scholar
• Norouzi, P.; Ganjali, M. R.; Sepehri, A.; Ghorbani, M. Novel Method for Fast Determination of Ultra Trace Amounts of Timolol Maleate by Continuous Cyclic Voltammetry at Au Microelectrode in Flowing Injection Systems. Sens. Actuators B Chem. 2005, 110, 239–245.
   Web of Science ®Google Scholar
• Mehta, J.; Patel, V.; Kshatri, N.; Vyas, N. A Versatile LC Method for the Simultaneous Quantification of Latanoprost, Timolol and Benzalkonium Chloride and Related Substances in the Presence of their Degradation Products in Ophthalmic Solution. Anal. Meth. 2010, 2, 1737–1744.
   Web of Science ®Google Scholar
• Rele, R. V.; Mhatre, V. V.; Parab, J. M.; Warkar, C. B. Simultaneous RP HPLC Determination of Latanoprost and Timolol Maleate in Combined Pharmaceutical Dosage Form. J. Chem. Pharm. Res. 2011, 3, 138–144.
   Google Scholar
• Mahajan, A.; Athensia, F.; Santosh Gandhi, V.; Padmanabh Deshpande, B. Development and Validation of High Performance Thin Layer Chromatographic Method for Estimation of Brimonidine Tartrate as Bulk Drug and in Ophthalmic Solutions. Int. J. Pharm. Tech. Res. 2010, 2, 1376–1379.
   Google Scholar
• Jain, P. S.; Khatal, R. N.; Jivani, H. N.; Surana, S. J. Development and Validation of TLC-Densitometry Method for Simultaneous Estimation of Brimonidine Tartrate and Timolol Maleate in Bulk and Pharmaceutical Dosage Form. J. Chromatogr. Sep. Techniq. 2011, 2, 113.
   Google Scholar
• Phogat, A.; Kumar, M. S.; Mahadevan, N. Simultaneous Estimation of Brimonidine Tartrate and Timolol Maleate in Nanoparticles Formulation by RP-HPLC. Int. J. Recent Adv. Pharm. Res. 2011, 3, 31–36.
   Google Scholar
• Hafez, M. H.; Elshanawane, A. A.; Abdelaziz, L. M.; Mohram, M. S. Development and Validation of HPLC Method for Simultaneous Estimation of Brimonidine Tartrate and Timolol Maleate in Bulk and Pharmaceutical Dosage Form. J. App. Pharm. 2014, 6, 398–407.
   Google Scholar
• Desai, H. H.; Captain, A. D. Three Simple Validated UV Spectrophotometric Methods for the Simultaneous Estimation of Timolol Maleate and Brimonidine Tartrate and Their Comparison Using ANOVA. Int. J. Pharm. Res. Anal. 2014, 4, 168–177.
   Google Scholar
• Mehta, S. K.; Maheshwari, D. G. Analytical Method Development and Validation for Simultaneous Estimation of Timolol Maleate and Brimonidine Tartrate in Bulk and Marketed Opthalmic Formulation. J. Pharm. Sci. Biosci. Res. 2014, 4, 351–356.
   Google Scholar
• Bro, R. PARAFAC. Tutorial and Applications. Chemometrics and Intelligent Laboratory Systems. Chemometr. Intell. Lab. Syst. 1997, 38, 149–171.
   Web of Science ®Google Scholar
• Tucker L. R. Some Mathematical Notes on Three-mode Factor Analysis. Psychometrika 1966, 31, 279–311.
   PubMed Web of Science ®Google Scholar
• Carroll, J. D.; Chang, J. J. Analysis of Individual Differences in Multidimensional Scaling Via an N-way Generalization of “Eckart-Young” Decomposition. Psychometrika 1970, 35, 283–319.
   Web of Science ®Google Scholar
• Harshman, R. A. Foundations of the PARAFAC Procedure: Models and Conditions for an “Explanatory” Multi-modal Factor Analysis. UCLA Working Papers Phonetics 1970, 16, 1–84.
   Google Scholar
• Tauler, R. Multivariate Curve Resolution Applied to Second Order Data. Chemometr. Intell. Lab. Syst. 1995, 30, 133–146.
   Web of Science ®Google Scholar
• Bro, R. Multiway Calibration. Multilinear PLS. J. Chemometr. 1996, 10, 47–61.
   Web of Science ®Google Scholar
• Smilde, A.; Bro, R.; Geladi, P. Multi‐way Analysis with Applications in the Chemical Sciences. Wiley: Chichester, 2004.
   Google Scholar
• Daszykowski, M.; Walczak, B. Use and Abuse of Chemometrics in Chromatography. TrAC Trends Anal. Chem. 2006, 25, 1081–1096.
   Web of Science ®Google Scholar
• Bro, R. Multi-way analysis in the food industry: models, algorithms, and applications. Ph.D. thesis. Universiteit van Amsterdam, 1998.
   Google Scholar
• Smilde, A. K. Comments on Multilinear PLS. J. Chemometr. 1997, 11, 367–377.
   Web of Science ®Google Scholar
• de Jong, S. Regression Coefficients in Multilinear PLS. J. Chemometr. 1998, 12, 77–81.
   Web of Science ®Google Scholar
• Bro, R.; Smilde, A. K.; de Jong, S. On the Difference Between Low-rank and Subspace Approximation: Improved Model for Multi-linear PLS Regression. Chemometr. Intell. Lab. Syst. 2001, 58, 3–13.
   Web of Science ®Google Scholar
• Bro, R.; Kiers, H. A. A New Efficient Method for Determining the Number of Components in PARAFAC Models. J. Chemometr. 2003, 17, 274–286.
   Web of Science ®Google Scholar